These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30705122)
1. p300 Mediates Muscle Wasting in Lewis Lung Carcinoma. Sin TK; Zhu JZ; Zhang G; Li YP Cancer Res; 2019 Apr; 79(7):1331-1342. PubMed ID: 30705122 [TBL] [Abstract][Full Text] [Related]
2. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia. Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162 [TBL] [Abstract][Full Text] [Related]
3. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. Zhang G; Jin B; Li YP EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090 [TBL] [Abstract][Full Text] [Related]
4. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300. Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181 [TBL] [Abstract][Full Text] [Related]
5. Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2. Zhang G; Lin RK; Kwon YT; Li YP FASEB J; 2013 Jul; 27(7):2893-901. PubMed ID: 23568773 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways. Zhang G; Liu Z; Ding H; Miao H; Garcia JM; Li YP Sci Rep; 2017 May; 7(1):2273. PubMed ID: 28536426 [TBL] [Abstract][Full Text] [Related]
7. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole. Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076 [TBL] [Abstract][Full Text] [Related]
9. Activin A induces skeletal muscle catabolism via p38β mitogen-activated protein kinase. Ding H; Zhang G; Sin KW; Liu Z; Lin RK; Li M; Li YP J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):202-212. PubMed ID: 27897407 [TBL] [Abstract][Full Text] [Related]
10. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia. AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202 [TBL] [Abstract][Full Text] [Related]
11. The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia. Bohnert KR; Goli P; Roy A; Sharma AK; Xiong G; Gallot YS; Kumar A Mol Cell Biol; 2019 Aug; 39(15):. PubMed ID: 31138662 [TBL] [Abstract][Full Text] [Related]
12. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia. Marchildon F; Lamarche É; Lala-Tabbert N; St-Louis C; Wiper-Bergeron N PLoS One; 2015; 10(12):e0145583. PubMed ID: 26709824 [TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90. Wu HY; Trevino JG; Fang BL; Riner AN; Vudatha V; Zhang GH; Li YP Cells; 2022 Sep; 11(17):. PubMed ID: 36078164 [TBL] [Abstract][Full Text] [Related]